Logo

American Heart Association

  18
  0


Final ID: Su3008

Left Bundle Branch Area Pacing Improves Mortality and Heart Failure Outcomes Compared to Right Ventricular Pacing in Atrioventricular Block: A Systematic Review and Meta-Analysis

Abstract Body (Do not enter title and authors here):
Background:
Left bundle branch area pacing (LBBAP) is an emerging physiologic pacing strategy that may offer advantages over conventional right ventricular pacing (RVP) in patients with atrioventricular (AV) block. This systematic review and meta-analysis evaluates the comparative safety and efficacy of LBBAP versus RVP.

Methods:
PubMed, Cochrane Library, and Google Scholar were systematically searched to identify studies comparing LBBAP and RVP in patients with AV block. Data were pooled using a random-effects model. Outcomes included paced QRS duration, all-cause mortality, heart failure hospitalization, left ventricular ejection fraction (LVEF), left ventricular diastolic diameter (LVDD), and periprocedural complications.

Results:
The meta-analysis examined nine studies (6 observational and three randomized controlled trials). The analysis of pacing parameters demonstrated significantly reduced paced QRS duration with LBBAP compared to RVP (MD [95% CI]: -35.91 [-40.68, -31.15], p-value < 0.00001), and primary outcomes revealed a significant reduction in all-cause mortality (RR [95% CI]: 0.49 [0.34, 0.72], p-value: 0.0002), and heart failure hospitalization associated with LBBAP (RR [95% CI]: 0.35 [0.23, 0.53], p-value: < 0.00001). Secondary outcomes, including periprocedural complications and changes in LVEF and LVDD exhibited non-significant increases in complications (RR [95% CI]: 1.14 [0.66, 1.95], p-value: < 0.64) and significant improvements in LVEF (MD [95% CI]: 3.35 [0.29, 6.35], p-value: 0.03). At the same time, LVDD showed a non-significant decrease (MD [95% CI]: -2.28 [-4.94, 0.37], p-value: 0.09).

Conclusion:
LBBAP demonstrates superior clinical outcomes compared to RVP in patients with AV block, including reduced mortality, heart failure hospitalization, and improved LVEF and paced QRS duration. Larger randomized trials are warranted to confirm these findings and guide clinical practice.
  • Khatri, Mahima  ( Jersey city medical centre , Jersey city , New Jersey , United States )
  • Kotak, Sohny  ( Dow University of Health Sciences , Karachi , Sindh , Pakistan )
  • Kothari, Janish  ( Jersey City Medical Centre , Jersey City , New Jersey , United States )
  • Author Disclosures:
    Mahima Khatri: DO NOT have relevant financial relationships | Sohny Kotak: DO NOT have relevant financial relationships | Janish Kothari: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Conduction System Pacing: Shaping the Future of Physiologic Pacing

Sunday, 11/09/2025 , 11:30AM - 12:30PM

Abstract Poster Board Session

More abstracts on this topic:
Acoramidis Reduces All-Cause Mortality (ACM) and Cardiovascular-Related Hospitalization (CVH): Initial Outcomes From the ATTRibute-CM Open-Label Extension (OLE) Study

Judge Daniel, Masri Ahmad, Obici Laura, Poulsen Steen, Sarswat Nitasha, Shah Keyur, Soman Prem, Cao Xiaofan, Wang Kevin, Pecoraro Maria, Tamby Jean-francois, Gillmore Julian, Katz Leonid, Fox Jonathan, Maurer Mathew, Alexander Kevin, Ambardekar Amrut, Cappelli Francesco, Fontana Marianna, Garcia-pavia Pablo, Grogan Martha, Hanna Mazen

A Bridge from Sweet to Sour: A Case of Recurrent Myocardial Stunning in Diabetic Ketoacidosis

Satish Vikyath, Pargaonkar Sumant, Slipczuk Leandro, Schenone Aldo, Maliha Maisha, Chi Kuan Yu, Sunil Kumar Sriram, Borkowski Pawel, Vyas Rhea, Rodriguez Szaszdi David Jose Javier, Kharawala Amrin, Seo Jiyoung

You have to be authorized to contact abstract author. Please, Login
Not Available